biote Corp.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$46M
↓-6.9% -$3Mvs FY2024 (Q4)
Gross Profit
$32M
↓-11.8% -$4Mvs FY2024 (Q4)
Operating Income
$7M
↑+146.8% +$4Mvs FY2024 (Q4)
Net Income
$2M
↓-20.6% -$508Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $46M | $50M |
| COGS | $15M | $14M |
| Gross Profit | $32M | $36M |
| R&D | $0 | $0 |
| SG&A | $25M | $33M |
| D&A | $0 | $265K |
| Other OpEx | $0 | $0 |
| Operating Income | $7M | $3M |
| Interest Exp. | $1M | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $6M | $3M |
| Tax | $4M | $305K |
| Net Income | $2M | $2M |
QuarterCharts · SEC EDGAR data · BTMD · Comparing FY2025 (Q4) vs FY2024 (Q4)